Celldex Presents CDX-1127 In Vitro Human Data Consistent With Strong Potency and Safety Profile at AACR 2013

[at noodls] – –Results Directly Complement Ongoing Clinical Development– NEEDHAM, Mass., April 8, 2013 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (Nasdaq:CLDX) today reported the results of an in vitro study analyzing … more

View todays social media effects on CLDX

View the latest stocks trending across Twitter. Click to view dashboard

See who Celldex is hiring next, click here to view